Basel Medical (BMGL) Receivables (2024 - 2025)
Basel Medical (BMGL) posted Receivables of $9.4 million for Q4 2025, up 26.47% sequentially from $7.4 million in Q2 2025, and down 39.98% YoY from $15.6 million in Q4 2024.
Powered by 
Analysis
Basel Medical (BMGL) Receivables (2024 - 2025) Analysis & Trends
Basel Medical has reported Receivables for 2 years, with the latest figure at $9.4 million in Q4 2025.
- Quarterly Receivables fell 39.98% year-over-year to $9.4 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $9.4 million (down 39.98% YoY) and the FY2025 annual result came in at $7.3 million, down 21.77% from the prior year.
- Receivables advanced to $9.4 million in Q4 2025 per BMGL's latest filing, from $7.4 million in the prior quarter.
- Over five years, Receivables peaked at $15.6 million in Q4 2024 and troughed at $7.4 million in Q2 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | HCA Healthcare | 89.47 Bn | 88.46 Bn | 15.19 Bn | 12.28 Bn |
| 2 | Tenet Healthcare | 22.09 Bn | 19.92 Bn | 4.45 Bn | 2.91 Bn |
| 3 | Encompass Health | 12.08 Bn | 11.95 Bn | 1.34 Bn | 687.30 Mn |
| 4 | Davita | 11.86 Bn | 11.17 Bn | 1.16 Bn | 3.03 Bn |
| 5 | Universal Health Services | 10.15 Bn | 10.01 Bn | 3.29 Bn | 2.80 Bn |
| 6 | Ensign | 9.93 Bn | 9.61 Bn | 306.24 Mn | 676.80 Mn |
| 7 | Chemed | 6.90 Bn | 6.86 Bn | 221.47 Mn | 188.63 Mn |
| 8 | Pacs | 6.73 Bn | 6.57 Bn | 338.46 Mn | 723.91 Mn |
| 9 | Concentra Group Holdings Parent | 4.31 Bn | 4.15 Bn | 192.10 Mn | 299.82 Mn |
| 10 | Basel Medical | 7.33 Mn | 6.54 Mn | - | 2.86 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 2.86 Mn |
| Jun 30, 2025 | 7.39 Mn |
| Dec 31, 2024 | 15.58 Mn |
| Jun 30, 2024 | 1.64 Mn |